A randomised controlled trial published in 2022 examined exenatide in individuals with AUD, finding no significant overall difference in alcohol consumption compared to placebo over a 26-week period, though a predefined subgroup analysis showed potential benefit specifically in participants with obesity
Retrieved July 4, 2026
Give your body time to adjust to the medication and recognize that progress may vary
Creighton CJ, Casa A, Lazard Z, Huang S, Tsimelzon A, Hilsenbeck SG, et al
On a separate Reddit thread, one bemoaned that they had pooped in public
Further research from CHI on Medicaid managed care will look at the experience of other states, examine these pitfalls and quantify the additional savings and costs of this new approach